PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$30.94

Market cap

$2.84B

P/E Ratio

49.9

Dividend/share

N/A

EPS

$0.62

Enterprise value

$2.81B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously ...

Highlights
PGNY's equity has surged by 51% year-on-year and by 11% since the previous quarter
The revenue is up by 43% year-on-year and by 10% since the previous quarter
PGNY's quick ratio is down by 8% since the previous quarter but it is up by 7% year-on-year
The EPS has declined by 16% since the previous quarter and by 7% year-on-year
The net income has contracted by 16% from the previous quarter and by 4.2% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.progyny.com

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
91.94M
Market cap
$2.84B
Enterprise value
$2.81B
Valuations
Price to earnings (P/E)
49.9
Price to book (P/B)
10.1
Price to sales (P/S)
5.14
EV/EBIT
138.86
EV/EBITDA
130.84
EV/Sales
5.11
Earnings
Revenue
$550.71M
EBIT
$20.26M
EBITDA
$21.5M
Free cash flow
$11.69M
Per share
EPS
$0.62
Free cash flow per share
$0.13
Book value per share
$3.06
Revenue per share
$6.02
TBVPS
$4.41
Balance sheet
Total assets
$415.53M
Total liabilities
$135.91M
Debt
$7.19M
Equity
$279.62M
Working capital
$180.31M
Liquidity
Debt to equity
0.03
Current ratio
2.4
Quick ratio
2.36
Net debt/EBITDA
-1.47
Margins
EBITDA margin
3.9%
Gross margin
21.1%
Net margin
10.1%
Operating margin
3.7%
Efficiency
Return on assets
15.6%
Return on equity
23.2%
Return on invested capital
11.6%
Return on capital employed
7.1%
Return on sales
3.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
4.18%
1 week
15.49%
1 month
-5.15%
1 year
-47.89%
YTD
-38.55%
QTD
-39.81%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$550.71M
Gross profit
$116.18M
Operating income
$20.48M
Net income
$55.57M
Gross margin
21.1%
Net margin
10.1%
PGNY's operating margin is down by 43% since the previous quarter and by 14% year-on-year
The revenue is up by 43% year-on-year and by 10% since the previous quarter
Progyny's gross profit has increased by 41% YoY and by 3.6% QoQ
Progyny's operating income has decreased by 37% QoQ but it has increased by 22% YoY

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
P/E
49.9
P/B
10.1
P/S
5.14
EV/EBIT
138.86
EV/EBITDA
130.84
EV/Sales
5.11
The stock's price to earnings (P/E) is 27% less than its last 4 quarters average of 68.0
The EPS has declined by 16% since the previous quarter and by 7% year-on-year
PGNY's price to book (P/B) is 51% lower than its last 4 quarters average of 20.7
PGNY's equity has surged by 51% year-on-year and by 11% since the previous quarter
PGNY's price to sales (P/S) is 48% lower than its last 4 quarters average of 9.9
The revenue is up by 43% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Progyny business performance
PGNY's return on invested capital is down by 44% since the previous quarter and by 35% year-on-year
The return on sales has declined by 42% since the previous quarter and by 14% year-on-year
The company's return on equity fell by 40% YoY and by 24% QoQ
Progyny's return on assets has decreased by 38% YoY and by 23% QoQ

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is up by 41% YoY and by 16% from the previous quarter
PGNY's total liabilities is up by 28% since the previous quarter and by 24% year-on-year
The company's debt is 97% lower than its equity
PGNY's equity has surged by 51% year-on-year and by 11% since the previous quarter
PGNY's debt to equity is down by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.